Directorate Change

MyHealthChecked PLC

26 June 2023

 

MyHealthChecked PLC

("MyHealthChecked" or the "Company")

Directorate Change

Appointment of Non-Executive Director

MyHealthChecked PLC (AIM: MHC), the consumer home-testing healthcare company, announces the proposed appointment of Amber Vodegel as a Non-Executive Director of the Company with effect 3 July 2023.

Amber is the Founder and original Owner of Health and Parenting Ltd, a HealthTech company that created the Company's flagship application Pregnancy+, one of the largest pregnancy apps worldwide, growing the user base to over two million daily active users. Amber managed Pregnancy+ as part of a suite of health apps under Health & Parenting Ltd from 2012 until the company was acquired by Philips in 2017. Following the acquisition she held the position of Business Leader and Transformation Advisor within Philips BG MCC. Amber has worked with MyHealthChecked in an advisory capacity for the past 5 months and brings to MyHealthChecked a strong knowledge of digital strategy in the healthcare space and a global network of contacts.  Amber also brings experience in mobile app development, digital transformation, and platform development for the Health- and FemTech space, with a focus on driving consumer obsession and maximising user engagement. Previously, Amber worked as a Strategy Director at a digital advertising agency with a focus on large social media campaigns as well as helping various Apps reach the number one position in their category.

Amber is the winner of the UK's 'First Women of Healthcare Award' and was shortlisted for the 2016 NatWest 'everywoman Awards'.

Penny McCormick, Chief Executive Officer of MyHealthChecked PLC, said: "It is a pleasure to welcome Amber to the Board of MyHealthChecked. Amber brings with her not only a wealth of experience in the health tech sector but also a passion and commitment to quality, ethics and the use of innovative technology to make the world a better place. Amber's experience in digital strategy hugely complements our business strategy and she is a fantastic addition to the MyHealthChecked team and our Board of Directors."

Commenting, Amber Vodegel, said: "I am thrilled to be part of the Board of MyHealthChecked, as my passion lies in supporting businesses that disrupt existing markets and create a positive impact in healthcare. Joining forces with this passionate team is truly a privilege, especially considering their impressive achievements through the successful launch of the innovative at-home testing range. It is an incredibly exciting time to be joining the business and I look forward to contributing to its growth."

The following additional information is provided in accordance with paragraph (g) of Schedule Two to the AIM Rules for Companies:

Amber Ilja Vodegel (49) is currently or has been a director of the following companies within the previous five years:

Current directorships/partnerships	Past directorships/partnerships
Consulens Limited	Ambion Consulting Ltd Ambion Investment Ltd

Ms Vodegel holds no  ordinary shares in the Company.

Save as set out above, no further information is required to be disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies.

For further information contact:

MyHealthChecked PLC		www.myhealthchecked.com
Penny McCormick, Chief Executive Officer		via Walbrook PR
SPARK Advisory Partners Limited (NOMAD)		Tel: [phone]
Neil Baldwin / Jade Bayat
Dowgate Capital Limited (Broker)		Tel: [phone]
David Poutney / Nicholas Chambers
Walbrook PR Ltd (Media & IR)	Tel: [phone] or [e-mail]
Paul McManus / Alice Woodings		Mob: [phone]

About MyHealthChecked PLC (https://investors.myhealthchecked.com/)

MyHealthChecked PLC, based in Cardiff, is an AIM-quoted pioneering UK healthcare company focused on a range of at-home healthcare and wellness tests.

MyHealthChecked is the umbrella brand of a range of at-home rapid tests, as well as DNA, RNA and blood sample collection kits which have been created to support customers on their journeys to wellness. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analysed in partner laboratories for a range of biomarkers. The tests will also be made available online and will be viable for over-the-counter purchase. 

The MyHealthChecked portfolio has been identified as part of a change in mindset as customers become more familiar with the concept of accessible healthcare in the growing at home testing kit market with a focus on accessibility at the right price, led by UK-based experts.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN (WITHDRAWAL) ACT 2018, AS AMENDED.  ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

END